Viewing nowCombinationAtectra Inhalation Capsule 150/80 Micrograms
Indacaterol Acetate 0.173mg · Mometasone Furoate 0.08mg
Prescription medication · Combination
Novartis Corporation

MFDS item code 202009234 · Approved 2020.12.24 · Insurance code 653603350
Maintenance treatment of asthma
This medication is suitable for the maintenance treatment of asthma in adults and adolescents aged 12 years and older, using a combination of a long-acting beta2 agonist and an inhaled corticosteroid. It helps to effectively control and prevent asthma symptoms when used once daily, improving respiratory health by allowing patients to manage their asthma symptoms well.
Adults and adolescents aged 12 years and older should inhale one capsule of this medication at 150/80 micrograms, 150/160 micrograms, or 150/320 micrograms once daily. The capsule should be inserted into the attached inhaler and inhaled orally; do not swallow the capsule. It should be taken at the same time daily and not exceed once a day.
The safety and efficacy of this medication have not been established in children under 12 years of age, and it is not recommended for this age group.
This medication should not be used in emergency situations such as acute asthma symptoms or acute bronchospasm. If a fast-acting bronchodilator is used more frequently than usual to relieve asthma symptoms, it is a sign that asthma is not well controlled, and medical attention should be sought. Asthma symptoms may recur or worsen while on this medication, so do not stop taking the medication without doctor supervision. Patients should consult healthcare providers immediately if their asthma symptoms do not improve or worsen. Allergic reactions may occur after using this medication, particularly symptoms such as difficulty breathing, swelling of the lips or face, hives, or skin rash; in such cases, use should be stopped immediately and alternative treatments should be sought. Rarely, this medication can cause paradoxical bronchospasm, which is where the bronchial tubes constrict more severely; if this occurs, stop the medication immediately and inform a healthcare professional. This medication contains lactose, so patients with lactose intolerance or related genetic conditions should not use it. Patients with heart disease, seizures, hyperthyroidism, hypokalemia, diabetes, pulmonary tuberculosis, or chronic infections should exercise special caution when using this medication and follow their doctor's instructions. The most common side effect of this medication is headache, but oral and throat pain or vocal cord dysfunction, musculoskeletal pain, and other side effects may occur as well. Rarely, symptoms such as angioedema, skin rash, or hyperglycemia may present. This medication may cause changes in heart rate or blood pressure, so patients with heart conditions should be particularly cautious. It may also lower blood potassium levels, which can affect heart health, but this is usually temporary. Diabetes patients should monitor their blood sugar levels more closely while taking this medication. Because this medication contains inhaled corticosteroids, long-term high-dose use may result in systemic side effects, so it is important to control asthma symptoms with the minimum effective dose. This medication may interact with other drugs; therefore, especially when using medications that prolong the QT interval, beta blockers, certain antidepressants, diuretics, etc., consulting with healthcare professionals is essential. During pregnancy, this medication may affect the fetus, and its use should only be considered if the benefits outweigh the risks, with careful management required for asthma during pregnancy. During breastfeeding, the components of this medication may transfer to breast milk; thus, the decision to use should consider potential effects on the nursing child. In case of overdose, symptoms such as abnormal heart rhythms, tremors, headache, or vomiting may occur; in severe cases, medical treatment may be required. This medication is for inhalation use only and should not be swallowed. Patients should familiarize themselves with the correct inhalation technique, take it at the same time every day, and rinse their mouth with water after use. Store the medication in a cool place below 25 degrees Celsius, away from moisture and light, and out of reach of children.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a cool place below 25 degrees Celsius, ensuring that it is protected from light and moisture. It is also important to keep it sealed in an airtight container.
Inhalation capsule with a white to almost white powder in a colorless, transparent upper and lower part (attached to the Breezhaler device)
30 capsules/pack
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationIndacaterol Acetate 0.173mg · Mometasone Furoate 0.08mg
Prescription medication · Combination
Novartis Corporation
CombinationIndacaterol Acetate 0.173mg · Mometasone Furoate 0.16mg
Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationIndacaterol Acetate 0.173mg · Mometasone Furoate 0.32mg
Prescription medication · Combination
Korea Novartis Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.